Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
14201
14202
14203
14204
14205
14206
14207
14208
14209
14210
14211
14212
14213
14214
14215
14216
14217
14218
14219
14220
14221
14222
14223
14224
14225
14226
14227
14228
14229
14230
14231
14232
14233
14234
14235
14236
14237
14238
14239
14240
14241
14242
14243
14244
14245
14246
14247
14248
14249
14250
14251
14252
14253
14254
14255
14256
14257
14258
14259
14260
14261
14262
14263
14264
14265
14266
14267
14268
14269
14270
14271
14272
14273
14274
14275
14276
14277
14278
14279
14280
14281
14282
14283
14284
14285
14286
14287
14288
14289
14290
14291
14292
14293
14294
14295
14296
14297
14298
14299
14300
14301
14302
14303
14304
14305
14306
14307
14308
14309
14310
14311
14312
14313
14314
14315
14316
14317
14318
14319
14320
14321
14322
14323
14324
14325
14326
14327
14328
14329
14330
14331
14332
14333
14334
14335
14336
14337
14338
14339
14340
14341
14342
14343
14344
14345
14346
14347
14348
14349
14350
14351
14352
14353
14354
14355
14356
14357
14358
14359
14360
14361
14362
14363
14364
14365
14366
14367
14368
14369
14370
14371
14372
14373
14374
14375
14376
14377
14378
14379
14380
14381
14382
14383
14384
14385
14386
14387
14388
14389
14390
14391
14392
14393
14394
14395
14396
14397
14398
14399
14400
| UnnamedSample_HQ_transcript/13979|m.5104 | UnnamedSample_HQ_transcript/13979 | Identity 0.901 too low. | d250aca382ec136348a47b3304793cfc | 693 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 121 | 175 | 1.6E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/13979|m.5104 | UnnamedSample_HQ_transcript/13979 | Identity 0.901 too low. | d250aca382ec136348a47b3304793cfc | 693 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 57 | 112 | 1.1E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/13979|m.5104 | UnnamedSample_HQ_transcript/13979 | Identity 0.901 too low. | d250aca382ec136348a47b3304793cfc | 693 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 561 | 670 | 3.5E-42 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/13979|m.5104 | UnnamedSample_HQ_transcript/13979 | Identity 0.901 too low. | d250aca382ec136348a47b3304793cfc | 693 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 451 | 556 | 1.0E-38 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/30554|m.9596 | UnnamedSample_HQ_transcript/30554 | Identity 0.869 too low. | d250aca382ec136348a47b3304793cfc | 693 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 385 | 442 | 6.2E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/30554|m.9596 | UnnamedSample_HQ_transcript/30554 | Identity 0.869 too low. | d250aca382ec136348a47b3304793cfc | 693 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 3 | 53 | 9.1E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/30554|m.9596 | UnnamedSample_HQ_transcript/30554 | Identity 0.869 too low. | d250aca382ec136348a47b3304793cfc | 693 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 172 | 230 | 2.5E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/30554|m.9596 | UnnamedSample_HQ_transcript/30554 | Identity 0.869 too low. | d250aca382ec136348a47b3304793cfc | 693 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 121 | 175 | 1.6E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/30554|m.9596 | UnnamedSample_HQ_transcript/30554 | Identity 0.869 too low. | d250aca382ec136348a47b3304793cfc | 693 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 57 | 112 | 1.1E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/30554|m.9596 | UnnamedSample_HQ_transcript/30554 | Identity 0.869 too low. | d250aca382ec136348a47b3304793cfc | 693 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 561 | 670 | 3.5E-42 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/30554|m.9596 | UnnamedSample_HQ_transcript/30554 | Identity 0.869 too low. | d250aca382ec136348a47b3304793cfc | 693 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 451 | 556 | 1.0E-38 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/32678|m.10129 | UnnamedSample_HQ_transcript/32678 | Coverage 0.503 too low. | 61adf9ae998b1d6020df63e3064678c8 | 513 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 334 | 470 | 3.3E-24 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/32678|m.10129 | UnnamedSample_HQ_transcript/32678 | Coverage 0.503 too low. | 61adf9ae998b1d6020df63e3064678c8 | 513 | Pfam | PF02190 | ATP-dependent protease La (LON) substrate-binding domain | 3 | 183 | 4.2E-14 | T | 22-09-2020 | IPR003111 | Lon, substrate-binding domain |
| UnnamedSample_HQ_transcript/54507|m.14945 | UnnamedSample_HQ_transcript/54507 | Coverage 0.729 too low. | 2f4797ac5207f5c258dc1b206166d445 | 547 | Pfam | PF00307 | Calponin homology (CH) domain | 40 | 142 | 3.8E-24 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/54507|m.14945 | UnnamedSample_HQ_transcript/54507 | Coverage 0.729 too low. | 2f4797ac5207f5c258dc1b206166d445 | 547 | Pfam | PF00307 | Calponin homology (CH) domain | 156 | 259 | 4.4E-21 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/21599|m.7308 | UnnamedSample_HQ_transcript/21599 | Coverage 0.449 too low. | 34f70820e94b7bd57b37945b41963015 | 750 | Pfam | PF14910 | S-phase genomic integrity recombination mediator, N-terminal | 4 | 413 | 4.3E-57 | T | 22-09-2020 | IPR029425 | Protein MMS22-like, N-terminal |
| UnnamedSample_HQ_transcript/21599|m.7308 | UnnamedSample_HQ_transcript/21599 | Coverage 0.449 too low. | 34f70820e94b7bd57b37945b41963015 | 750 | Pfam | PF14911 | S-phase genomic integrity recombination mediator, C-terminal | 532 | 750 | 7.7E-38 | T | 22-09-2020 | IPR029424 | MMS22-like, C-terminal |
| UnnamedSample_HQ_transcript/21694|m.7340 | UnnamedSample_HQ_transcript/21694 | Coverage 0.834 too low. | 603deceb1587ee82e91ab1ad8222ec4f | 745 | Pfam | PF00533 | BRCA1 C Terminus (BRCT) domain | 120 | 191 | 8.0E-6 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/21694|m.7340 | UnnamedSample_HQ_transcript/21694 | Coverage 0.834 too low. | 603deceb1587ee82e91ab1ad8222ec4f | 745 | Pfam | PF12738 | twin BRCT domain | 31 | 93 | 3.8E-17 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/21694|m.7340 | UnnamedSample_HQ_transcript/21694 | Coverage 0.834 too low. | 603deceb1587ee82e91ab1ad8222ec4f | 745 | Pfam | PF00621 | RhoGEF domain | 305 | 486 | 4.3E-41 | T | 22-09-2020 | IPR000219 | Dbl homology (DH) domain |
| UnnamedSample_HQ_transcript/107274|m.23494 | UnnamedSample_HQ_transcript/107274 | Coverage 0.901 too low. | 5167198e3949440d25bd79be3b5ceb9b | 282 | Pfam | PF12066 | SERRATE/Ars2, N-terminal domain | 136 | 245 | 5.8E-37 | T | 22-09-2020 | IPR021933 | SERRATE/Ars2, N-terminal |
| UnnamedSample_HQ_transcript/24896|m.8194 | UnnamedSample_HQ_transcript/24896 | Coverage 0.875 too low. | be42668e6aed7abbe54f86fc2393968d | 414 | Pfam | PF06702 | Golgi casein kinase, C-terminal, Fam20 | 294 | 413 | 1.2E-53 | T | 22-09-2020 | IPR009581 | FAM20, C-terminal |
| UnnamedSample_HQ_transcript/74205|m.18684 | UnnamedSample_HQ_transcript/74205 | Coverage 0.951 too low. | 10480f5d36d1f372ff994e49c9a6dce4 | 528 | Pfam | PF00498 | FHA domain | 294 | 370 | 1.1E-12 | T | 22-09-2020 | IPR000253 | Forkhead-associated (FHA) domain |
| UnnamedSample_HQ_transcript/74205|m.18684 | UnnamedSample_HQ_transcript/74205 | Coverage 0.951 too low. | 10480f5d36d1f372ff994e49c9a6dce4 | 528 | Pfam | PF01585 | G-patch domain | 474 | 517 | 6.9E-15 | T | 22-09-2020 | IPR000467 | G-patch domain |
| UnnamedSample_HQ_transcript/74205|m.18684 | UnnamedSample_HQ_transcript/74205 | Coverage 0.951 too low. | 10480f5d36d1f372ff994e49c9a6dce4 | 528 | Pfam | PF17780 | OCRE domain | 114 | 164 | 1.6E-16 | T | 22-09-2020 | IPR041591 | OCRE domain |
| UnnamedSample_HQ_transcript/34462|m.10597 | UnnamedSample_HQ_transcript/34462 | Coverage 0.777 too low. | 174c532706e04beb15c961b9aa18f676 | 747 | Pfam | PF00435 | Spectrin repeat | 532 | 632 | 1.0E-7 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/34462|m.10597 | UnnamedSample_HQ_transcript/34462 | Coverage 0.777 too low. | 174c532706e04beb15c961b9aa18f676 | 747 | Pfam | PF00435 | Spectrin repeat | 638 | 710 | 7.1E-8 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/34462|m.10597 | UnnamedSample_HQ_transcript/34462 | Coverage 0.777 too low. | 174c532706e04beb15c961b9aa18f676 | 747 | Pfam | PF00307 | Calponin homology (CH) domain | 40 | 142 | 6.1E-24 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/34462|m.10597 | UnnamedSample_HQ_transcript/34462 | Coverage 0.777 too low. | 174c532706e04beb15c961b9aa18f676 | 747 | Pfam | PF00307 | Calponin homology (CH) domain | 156 | 259 | 7.2E-21 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/34462|m.10597 | UnnamedSample_HQ_transcript/34462 | Coverage 0.777 too low. | 174c532706e04beb15c961b9aa18f676 | 747 | Pfam | PF17902 | SH3 domain | 706 | 746 | 1.2E-11 | T | 22-09-2020 | IPR041615 | Desmoplakin, SH3 domain |
| UnnamedSample_HQ_transcript/41926|m.12246 | UnnamedSample_HQ_transcript/41926 | Coverage 0.188 too low. | 90440d1e3817e18b3524595421317b57 | 393 | Pfam | PF00069 | Protein kinase domain | 82 | 359 | 4.0E-65 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/4028|m.1814 | UnnamedSample_HQ_transcript/4028 | Identity 0.937 too low. | 4d8e5f35a838b9724810e23cb43cb0ee | 1590 | Pfam | PF06202 | Amylo-alpha-1,6-glucosidase | 1128 | 1577 | 1.6E-127 | T | 22-09-2020 | IPR032790 | Glycogen debranching enzyme, C-terminal |
| UnnamedSample_HQ_transcript/4028|m.1814 | UnnamedSample_HQ_transcript/4028 | Identity 0.937 too low. | 4d8e5f35a838b9724810e23cb43cb0ee | 1590 | Pfam | PF14702 | Central domain of human glycogen debranching enzyme | 778 | 1029 | 1.3E-69 | T | 22-09-2020 | IPR032788 | Glycogen debranching enzyme, central domain |
| UnnamedSample_HQ_transcript/4028|m.1814 | UnnamedSample_HQ_transcript/4028 | Identity 0.937 too low. | 4d8e5f35a838b9724810e23cb43cb0ee | 1590 | Pfam | PF14701 | Glycogen debranching enzyme, glucanotransferase domain | 206 | 639 | 1.0E-149 | T | 22-09-2020 | IPR032792 | Glycogen debranching enzyme, glucanotransferase domain |
| UnnamedSample_HQ_transcript/4028|m.1814 | UnnamedSample_HQ_transcript/4028 | Identity 0.937 too low. | 4d8e5f35a838b9724810e23cb43cb0ee | 1590 | Pfam | PF14699 | N-terminal domain from the human glycogen debranching enzyme | 118 | 200 | 4.0E-20 | T | 22-09-2020 | IPR029436 | Eukaryotic glycogen debranching enzyme, N-terminal domain |
| UnnamedSample_HQ_transcript/37999|m.11393 | UnnamedSample_HQ_transcript/37999 | Coverage 0.705 too low. | 8095486df6220354b104ed4e36e57905 | 636 | Pfam | PF07727 | Reverse transcriptase (RNA-dependent DNA polymerase) | 164 | 397 | 6.5E-60 | T | 22-09-2020 | IPR013103 | Reverse transcriptase, RNA-dependent DNA polymerase |
| UnnamedSample_HQ_transcript/3971|m.1797 | UnnamedSample_HQ_transcript/3971 | Coverage 0.887 too low. | f6107412b089c51f81ac2564a8a15ba0 | 1348 | Pfam | PF00005 | ABC transporter | 1056 | 1199 | 3.9E-23 | T | 22-09-2020 | IPR003439 | ABC transporter-like |
| UnnamedSample_HQ_transcript/3971|m.1797 | UnnamedSample_HQ_transcript/3971 | Coverage 0.887 too low. | f6107412b089c51f81ac2564a8a15ba0 | 1348 | Pfam | PF00005 | ABC transporter | 226 | 369 | 2.7E-27 | T | 22-09-2020 | IPR003439 | ABC transporter-like |
| UnnamedSample_HQ_transcript/3971|m.1797 | UnnamedSample_HQ_transcript/3971 | Coverage 0.887 too low. | f6107412b089c51f81ac2564a8a15ba0 | 1348 | Pfam | PF12698 | ABC-2 family transporter protein | 591 | 973 | 5.6E-34 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/15642|m.5596 | UnnamedSample_HQ_transcript/15642 | Coverage 0.118 too low. | d75d411f6aa206677208bb9188c82ab0 | 511 | Pfam | PF00335 | Tetraspanin family | 66 | 330 | 1.3E-21 | T | 22-09-2020 | IPR018499 | Tetraspanin/Peripherin |
| UnnamedSample_HQ_transcript/21878|m.7391 | UnnamedSample_HQ_transcript/21878 | Unmapped. | 653dc3961dc9af18823faf402c9f480d | 467 | Pfam | PF08762 | CRPV capsid protein like | 294 | 445 | 5.7E-10 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/62513|m.16541 | UnnamedSample_HQ_transcript/62513 | Coverage 0.889 too low. | ece8c70ef6f3871cfc158757d627a4a1 | 433 | Pfam | PF01496 | V-type ATPase 116kDa subunit family | 1 | 421 | 4.3E-169 | T | 22-09-2020 | IPR002490 | V-type ATPase, V0 complex, 116kDa subunit family |
| UnnamedSample_HQ_transcript/28365|m.9058 | UnnamedSample_HQ_transcript/28365 | Coverage 0.244 too low. | 15784d3351cb7de908ac27064af5a59f | 229 | Pfam | PF00595 | PDZ domain | 96 | 171 | 7.5E-18 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/28365|m.9058 | UnnamedSample_HQ_transcript/28365 | Coverage 0.244 too low. | 15784d3351cb7de908ac27064af5a59f | 229 | Pfam | PF00595 | PDZ domain | 2 | 72 | 2.5E-16 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/29792|m.9420 | UnnamedSample_HQ_transcript/29792 | Coverage 0.389 too low. | abd10c109f5213f47cecf2717a39391e | 392 | Pfam | PF01412 | Putative GTPase activating protein for Arf | 16 | 124 | 2.0E-26 | T | 22-09-2020 | IPR001164 | Arf GTPase activating protein |
| UnnamedSample_HQ_transcript/28869|m.9190 | UnnamedSample_HQ_transcript/28869 | Coverage 0.948 too low. | 306df6d8f4de3c506f5693595e4ba18d | 233 | Pfam | PF01553 | Acyltransferase | 14 | 134 | 1.7E-18 | T | 22-09-2020 | IPR002123 | Phospholipid/glycerol acyltransferase |
| UnnamedSample_HQ_transcript/96323|m.22142 | UnnamedSample_HQ_transcript/96323 | Coverage 0.964 too low. | af66dbc8490d66724936ffe3fa537b8c | 348 | Pfam | PF03399 | SAC3/GANP family | 13 | 303 | 6.2E-68 | T | 22-09-2020 | IPR005062 | SAC3/GANP/THP3 |
| UnnamedSample_HQ_transcript/100010|m.22632 | UnnamedSample_HQ_transcript/100010 | Coverage 0.962 too low. | af66dbc8490d66724936ffe3fa537b8c | 348 | Pfam | PF03399 | SAC3/GANP family | 13 | 303 | 6.2E-68 | T | 22-09-2020 | IPR005062 | SAC3/GANP/THP3 |
| UnnamedSample_HQ_transcript/60821|m.16224 | UnnamedSample_HQ_transcript/60821 | Coverage 0.484 too low. | b308e5ced8616f11551260b875701e41 | 562 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 150 | 540 | 6.1E-103 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/81066|m.19896 | UnnamedSample_HQ_transcript/81066 | Coverage 0.927 too low. | 8add34047ed3288456e2d015bf9544d3 | 383 | Pfam | PF05362 | Lon protease (S16) C-terminal proteolytic domain | 169 | 376 | 7.4E-74 | T | 22-09-2020 | IPR008269 | Peptidase S16, Lon proteolytic domain |
| UnnamedSample_HQ_transcript/81066|m.19896 | UnnamedSample_HQ_transcript/81066 | Coverage 0.927 too low. | 8add34047ed3288456e2d015bf9544d3 | 383 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 4 | 87 | 4.7E-9 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/77848|m.19347 | UnnamedSample_HQ_transcript/77848 | Coverage 0.653 too low. | 5999dea904bed73b542010375c664f7c | 466 | Pfam | PF00089 | Trypsin | 208 | 421 | 6.4E-16 | T | 22-09-2020 | IPR001254 | Serine proteases, trypsin domain |
| UnnamedSample_HQ_transcript/72662|m.18416 | UnnamedSample_HQ_transcript/72662 | Coverage 0.667 too low. | 5999dea904bed73b542010375c664f7c | 466 | Pfam | PF00089 | Trypsin | 208 | 421 | 6.4E-16 | T | 22-09-2020 | IPR001254 | Serine proteases, trypsin domain |
| UnnamedSample_HQ_transcript/31492|m.9831 | UnnamedSample_HQ_transcript/31492 | Coverage 0.528 too low. | 243f8f0b3201ec632b5a3a419b73532f | 481 | Pfam | PF00096 | Zinc finger, C2H2 type | 416 | 436 | 0.0023 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/31492|m.9831 | UnnamedSample_HQ_transcript/31492 | Coverage 0.528 too low. | 243f8f0b3201ec632b5a3a419b73532f | 481 | Pfam | PF00096 | Zinc finger, C2H2 type | 445 | 468 | 7.7E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/31492|m.9831 | UnnamedSample_HQ_transcript/31492 | Coverage 0.528 too low. | 243f8f0b3201ec632b5a3a419b73532f | 481 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.7E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/21710|m.7346 | UnnamedSample_HQ_transcript/21710 | Coverage 0.988 too low. | ed4d11d0a6ed3d4513c3db8ca6014f7f | 991 | Pfam | PF00204 | DNA gyrase B | 268 | 428 | 4.5E-26 | T | 22-09-2020 | IPR013506 | DNA topoisomerase, type IIA, subunit B, domain 2 |
| UnnamedSample_HQ_transcript/21710|m.7346 | UnnamedSample_HQ_transcript/21710 | Coverage 0.988 too low. | ed4d11d0a6ed3d4513c3db8ca6014f7f | 991 | Pfam | PF00521 | DNA gyrase/topoisomerase IV, subunit A | 718 | 990 | 5.7E-93 | T | 22-09-2020 | IPR002205 | DNA topoisomerase, type IIA, subunit A/C-terminal |
| UnnamedSample_HQ_transcript/21710|m.7346 | UnnamedSample_HQ_transcript/21710 | Coverage 0.988 too low. | ed4d11d0a6ed3d4513c3db8ca6014f7f | 991 | Pfam | PF16898 | C-terminal associated domain of TOPRIM | 573 | 716 | 6.4E-48 | T | 22-09-2020 | IPR031660 | C-terminal associated domain of TOPRIM |
| UnnamedSample_HQ_transcript/21710|m.7346 | UnnamedSample_HQ_transcript/21710 | Coverage 0.988 too low. | ed4d11d0a6ed3d4513c3db8ca6014f7f | 991 | Pfam | PF02518 | Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase | 81 | 225 | 1.0E-15 | T | 22-09-2020 | IPR003594 | Histidine kinase/HSP90-like ATPase |
| UnnamedSample_HQ_transcript/21710|m.7346 | UnnamedSample_HQ_transcript/21710 | Coverage 0.988 too low. | ed4d11d0a6ed3d4513c3db8ca6014f7f | 991 | Pfam | PF01751 | Toprim domain | 457 | 558 | 5.1E-8 | T | 22-09-2020 | IPR006171 | TOPRIM domain |
| UnnamedSample_HQ_transcript/23668|m.7850 | UnnamedSample_HQ_transcript/23668 | Identity 0.948 too low. | ed4d11d0a6ed3d4513c3db8ca6014f7f | 991 | Pfam | PF00204 | DNA gyrase B | 268 | 428 | 4.5E-26 | T | 22-09-2020 | IPR013506 | DNA topoisomerase, type IIA, subunit B, domain 2 |
| UnnamedSample_HQ_transcript/23668|m.7850 | UnnamedSample_HQ_transcript/23668 | Identity 0.948 too low. | ed4d11d0a6ed3d4513c3db8ca6014f7f | 991 | Pfam | PF00521 | DNA gyrase/topoisomerase IV, subunit A | 718 | 990 | 5.7E-93 | T | 22-09-2020 | IPR002205 | DNA topoisomerase, type IIA, subunit A/C-terminal |
| UnnamedSample_HQ_transcript/23668|m.7850 | UnnamedSample_HQ_transcript/23668 | Identity 0.948 too low. | ed4d11d0a6ed3d4513c3db8ca6014f7f | 991 | Pfam | PF16898 | C-terminal associated domain of TOPRIM | 573 | 716 | 6.4E-48 | T | 22-09-2020 | IPR031660 | C-terminal associated domain of TOPRIM |
| UnnamedSample_HQ_transcript/23668|m.7850 | UnnamedSample_HQ_transcript/23668 | Identity 0.948 too low. | ed4d11d0a6ed3d4513c3db8ca6014f7f | 991 | Pfam | PF02518 | Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase | 81 | 225 | 1.0E-15 | T | 22-09-2020 | IPR003594 | Histidine kinase/HSP90-like ATPase |
| UnnamedSample_HQ_transcript/23668|m.7850 | UnnamedSample_HQ_transcript/23668 | Identity 0.948 too low. | ed4d11d0a6ed3d4513c3db8ca6014f7f | 991 | Pfam | PF01751 | Toprim domain | 457 | 558 | 5.1E-8 | T | 22-09-2020 | IPR006171 | TOPRIM domain |
| UnnamedSample_HQ_transcript/5584|m.2385 | UnnamedSample_HQ_transcript/5584 | Coverage 0.509 too low. | d89379eb4d09c6d17c7271ab72b8ad0c | 1261 | Pfam | PF00169 | PH domain | 541 | 639 | 1.7E-9 | T | 22-09-2020 | IPR001849 | Pleckstrin homology domain |
| UnnamedSample_HQ_transcript/5584|m.2385 | UnnamedSample_HQ_transcript/5584 | Coverage 0.509 too low. | d89379eb4d09c6d17c7271ab72b8ad0c | 1261 | Pfam | PF00169 | PH domain | 431 | 523 | 1.3E-10 | T | 22-09-2020 | IPR001849 | Pleckstrin homology domain |
| UnnamedSample_HQ_transcript/5584|m.2385 | UnnamedSample_HQ_transcript/5584 | Coverage 0.509 too low. | d89379eb4d09c6d17c7271ab72b8ad0c | 1261 | Pfam | PF00373 | FERM central domain | 998 | 1128 | 3.0E-15 | T | 22-09-2020 | IPR019748 | FERM central domain |
| UnnamedSample_HQ_transcript/5584|m.2385 | UnnamedSample_HQ_transcript/5584 | Coverage 0.509 too low. | d89379eb4d09c6d17c7271ab72b8ad0c | 1261 | Pfam | PF00784 | MyTH4 domain | 802 | 880 | 1.5E-20 | T | 22-09-2020 | IPR000857 | MyTH4 domain |
| UnnamedSample_HQ_transcript/5584|m.2385 | UnnamedSample_HQ_transcript/5584 | Coverage 0.509 too low. | d89379eb4d09c6d17c7271ab72b8ad0c | 1261 | Pfam | PF00784 | MyTH4 domain | 725 | 775 | 1.3E-6 | T | 22-09-2020 | IPR000857 | MyTH4 domain |
| UnnamedSample_HQ_transcript/46264|m.13201 | UnnamedSample_HQ_transcript/46264 | Coverage 0.917 too low. | 8b784633b193c71682af5bc0e91c058e | 563 | Pfam | PF00240 | Ubiquitin family | 30 | 96 | 1.2E-6 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/64647|m.16971 | UnnamedSample_HQ_transcript/64647 | Unmapped. | 22480b582519342095c2787ca6a00f97 | 156 | Pfam | PF00885 | 6,7-dimethyl-8-ribityllumazine synthase | 13 | 151 | 1.8E-54 | T | 22-09-2020 | IPR002180 | Lumazine/riboflavin synthase |
| UnnamedSample_HQ_transcript/17934|m.6279 | UnnamedSample_HQ_transcript/17934 | Coverage 0.870 too low. | f23d7d768bd283d1a0c64f4b3798e40f | 520 | Pfam | PF16041 | Domain of unknown function (DUF4793) | 409 | 516 | 2.4E-29 | T | 22-09-2020 | IPR032010 | Domain of unknown function DUF4793 |
| UnnamedSample_HQ_transcript/17934|m.6279 | UnnamedSample_HQ_transcript/17934 | Coverage 0.870 too low. | f23d7d768bd283d1a0c64f4b3798e40f | 520 | Pfam | PF16040 | Domain of unknown function (DUF4792) | 21 | 90 | 1.3E-21 | T | 22-09-2020 | IPR032008 | Domain of unknown function DUF4792 |
| UnnamedSample_HQ_transcript/20486|m.7005 | UnnamedSample_HQ_transcript/20486 | Coverage 0.045 too low. | cad33f92f62389b8de6cc6c00f338d90 | 480 | Pfam | PF00780 | CNH domain | 173 | 450 | 1.5E-62 | T | 22-09-2020 | IPR001180 | Citron homology (CNH) domain |
| UnnamedSample_HQ_transcript/21701|m.7345 | UnnamedSample_HQ_transcript/21701 | Coverage 0.829 too low. | cad33f92f62389b8de6cc6c00f338d90 | 480 | Pfam | PF00780 | CNH domain | 173 | 450 | 1.5E-62 | T | 22-09-2020 | IPR001180 | Citron homology (CNH) domain |
| UnnamedSample_HQ_transcript/94462|m.21867 | UnnamedSample_HQ_transcript/94462 | Coverage 0.342 too low. | 8b18fd8e7b57134dc71cb61e1e0b918a | 364 | Pfam | PF04666 | N-Acetylglucosaminyltransferase-IV (GnT-IV) conserved region | 119 | 363 | 1.6E-95 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/109938|m.23822 | UnnamedSample_HQ_transcript/109938 | Coverage 0.980 too low. | 0b2803e9d6c7b9f4744946fec1cd6b29 | 188 | Pfam | PF00011 | Hsp20/alpha crystallin family | 73 | 169 | 1.3E-26 | T | 22-09-2020 | IPR002068 | Alpha crystallin/Hsp20 domain |
| UnnamedSample_HQ_transcript/36251|m.10990 | UnnamedSample_HQ_transcript/36251 | Coverage 0.270 too low. | 9f4597a9e6c684b88bb62f9ad89cc832 | 275 | Pfam | PF00100 | Zona pellucida-like domain | 7 | 96 | 8.2E-8 | T | 22-09-2020 | IPR001507 | Zona pellucida domain |
| UnnamedSample_HQ_transcript/49751|m.13968 | UnnamedSample_HQ_transcript/49751 | Coverage 0.660 too low. | e563016049641c39e50542e8cb160770 | 589 | Pfam | PF18004 | 26S proteasome regulatory subunit RPN2 C-terminal domain | 364 | 556 | 2.2E-43 | T | 22-09-2020 | IPR040623 | 26S proteasome regulatory subunit RPN2, C-terminal |
| UnnamedSample_HQ_transcript/49751|m.13968 | UnnamedSample_HQ_transcript/49751 | Coverage 0.660 too low. | e563016049641c39e50542e8cb160770 | 589 | Pfam | PF13646 | HEAT repeats | 178 | 268 | 4.1E-13 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/93214|m.21699 | UnnamedSample_HQ_transcript/93214 | Coverage 0.797 too low. | cbf94c4e82489f56c8e1654578a19508 | 230 | Pfam | PF02188 | GoLoco motif | 207 | 226 | 3.0E-10 | T | 22-09-2020 | IPR003109 | GoLoco motif |
| UnnamedSample_HQ_transcript/93214|m.21699 | UnnamedSample_HQ_transcript/93214 | Coverage 0.797 too low. | cbf94c4e82489f56c8e1654578a19508 | 230 | Pfam | PF02188 | GoLoco motif | 125 | 146 | 6.1E-9 | T | 22-09-2020 | IPR003109 | GoLoco motif |
| UnnamedSample_HQ_transcript/93214|m.21699 | UnnamedSample_HQ_transcript/93214 | Coverage 0.797 too low. | cbf94c4e82489f56c8e1654578a19508 | 230 | Pfam | PF02188 | GoLoco motif | 76 | 97 | 7.1E-12 | T | 22-09-2020 | IPR003109 | GoLoco motif |
| UnnamedSample_HQ_transcript/94230|m.21838 | UnnamedSample_HQ_transcript/94230 | Coverage 0.243 too low. | 6b017ec4d600dc0fa325a5c477dd3d8a | 243 | Pfam | PF15035 | Ciliary rootlet component, centrosome cohesion | 25 | 223 | 8.4E-64 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/46352|m.13219 | UnnamedSample_HQ_transcript/46352 | Identity 0.774 too low. | 85169cf3c78516dfa8f40468dad2da16 | 169 | Pfam | PF00022 | Actin | 1 | 167 | 1.6E-54 | T | 22-09-2020 | IPR004000 | Actin family |
| UnnamedSample_HQ_transcript/75912|m.19001 | UnnamedSample_HQ_transcript/75912 | Coverage 0.987 too low. | a253741c50335a0555e39820f7159a05 | 479 | Pfam | PF00372 | Hemocyanin, copper containing domain | 1 | 180 | 2.3E-37 | T | 22-09-2020 | IPR000896 | Hemocyanin/hexamerin middle domain |
| UnnamedSample_HQ_transcript/75912|m.19001 | UnnamedSample_HQ_transcript/75912 | Coverage 0.987 too low. | a253741c50335a0555e39820f7159a05 | 479 | Pfam | PF03723 | Hemocyanin, ig-like domain | 189 | 471 | 1.5E-60 | T | 22-09-2020 | IPR005203 | Hemocyanin, C-terminal |
| UnnamedSample_HQ_transcript/103865|m.23091 | UnnamedSample_HQ_transcript/103865 | Coverage 0.698 too low. | 3c5415f744c162fdfbf6ef554f73da44 | 274 | Pfam | PF08614 | Autophagy protein 16 (ATG16) | 2 | 98 | 3.3E-17 | T | 22-09-2020 | IPR013923 | Autophagy-related protein 16 |
| UnnamedSample_HQ_transcript/103865|m.23091 | UnnamedSample_HQ_transcript/103865 | Coverage 0.698 too low. | 3c5415f744c162fdfbf6ef554f73da44 | 274 | Pfam | PF00400 | WD domain, G-beta repeat | 151 | 186 | 2.9E-7 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/25678|m.8391 | UnnamedSample_HQ_transcript/25678 | Coverage 0.301 too low. | 3698bf5a41f912701c27709a8efb605c | 747 | Pfam | PF18100 | Phosphodiesterase 4 upstream conserved regions (UCR) | 178 | 296 | 1.6E-53 | T | 22-09-2020 | IPR040844 | Phosphodiesterase 4 upstream conserved regions (UCR) |
| UnnamedSample_HQ_transcript/25678|m.8391 | UnnamedSample_HQ_transcript/25678 | Coverage 0.301 too low. | 3698bf5a41f912701c27709a8efb605c | 747 | Pfam | PF00233 | 3'5'-cyclic nucleotide phosphodiesterase | 438 | 679 | 4.3E-91 | T | 22-09-2020 | IPR002073 | 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain |
| UnnamedSample_HQ_transcript/21567|m.7299 | UnnamedSample_HQ_transcript/21567 | Coverage 0.284 too low. | 3698bf5a41f912701c27709a8efb605c | 747 | Pfam | PF18100 | Phosphodiesterase 4 upstream conserved regions (UCR) | 178 | 296 | 1.6E-53 | T | 22-09-2020 | IPR040844 | Phosphodiesterase 4 upstream conserved regions (UCR) |
| UnnamedSample_HQ_transcript/21567|m.7299 | UnnamedSample_HQ_transcript/21567 | Coverage 0.284 too low. | 3698bf5a41f912701c27709a8efb605c | 747 | Pfam | PF00233 | 3'5'-cyclic nucleotide phosphodiesterase | 438 | 679 | 4.3E-91 | T | 22-09-2020 | IPR002073 | 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain |
| UnnamedSample_HQ_transcript/1285|m.759 | UnnamedSample_HQ_transcript/1285 | Coverage 0.461 too low. | 5a5fd5b7b51c2cffe282dcb38edbcee4 | 402 | Pfam | PF03165 | MH1 domain | 59 | 143 | 4.6E-22 | T | 22-09-2020 | IPR003619 | MAD homology 1, Dwarfin-type |
| UnnamedSample_HQ_transcript/1285|m.759 | UnnamedSample_HQ_transcript/1285 | Coverage 0.461 too low. | 5a5fd5b7b51c2cffe282dcb38edbcee4 | 402 | Pfam | PF03166 | MH2 domain | 229 | 398 | 1.4E-44 | T | 22-09-2020 | IPR001132 | SMAD domain, Dwarfin-type |
| UnnamedSample_HQ_transcript/16557|m.5876 | UnnamedSample_HQ_transcript/16557 | Coverage 0.831 too low. | 5a5fd5b7b51c2cffe282dcb38edbcee4 | 402 | Pfam | PF03165 | MH1 domain | 59 | 143 | 4.6E-22 | T | 22-09-2020 | IPR003619 | MAD homology 1, Dwarfin-type |
| UnnamedSample_HQ_transcript/16557|m.5876 | UnnamedSample_HQ_transcript/16557 | Coverage 0.831 too low. | 5a5fd5b7b51c2cffe282dcb38edbcee4 | 402 | Pfam | PF03166 | MH2 domain | 229 | 398 | 1.4E-44 | T | 22-09-2020 | IPR001132 | SMAD domain, Dwarfin-type |
| UnnamedSample_HQ_transcript/18053|m.6316 | UnnamedSample_HQ_transcript/18053 | Coverage 0.853 too low. | 5a5fd5b7b51c2cffe282dcb38edbcee4 | 402 | Pfam | PF03165 | MH1 domain | 59 | 143 | 4.6E-22 | T | 22-09-2020 | IPR003619 | MAD homology 1, Dwarfin-type |
| UnnamedSample_HQ_transcript/18053|m.6316 | UnnamedSample_HQ_transcript/18053 | Coverage 0.853 too low. | 5a5fd5b7b51c2cffe282dcb38edbcee4 | 402 | Pfam | PF03166 | MH2 domain | 229 | 398 | 1.4E-44 | T | 22-09-2020 | IPR001132 | SMAD domain, Dwarfin-type |
| UnnamedSample_HQ_transcript/25661|m.8387 | UnnamedSample_HQ_transcript/25661 | Unmapped. | 7d77d246949fc3eace27f11bf66f34a7 | 964 | Pfam | PF17222 | Viral cysteine endopeptidase C107 | 8 | 263 | 4.0E-11 | T | 22-09-2020 | IPR033777 | Viral cysteine endopeptidase C107 |
| UnnamedSample_HQ_transcript/16907|m.5973 | UnnamedSample_HQ_transcript/16907 | Coverage 0.241 too low. | 35f6555ac76ef5ef586cd772c0ef595b | 462 | Pfam | PF02181 | Formin Homology 2 Domain | 348 | 456 | 6.1E-11 | T | 22-09-2020 | IPR015425 | Formin, FH2 domain |
| UnnamedSample_HQ_transcript/16907|m.5973 | UnnamedSample_HQ_transcript/16907 | Coverage 0.241 too low. | 35f6555ac76ef5ef586cd772c0ef595b | 462 | Pfam | PF06367 | Diaphanous FH3 Domain | 49 | 230 | 5.3E-29 | T | 22-09-2020 | IPR010472 | Formin, FH3 domain |
| UnnamedSample_HQ_transcript/24662|m.8120 | UnnamedSample_HQ_transcript/24662 | Coverage 0.780 too low. | d3084ccdc5013113eea4b85fd76d8002 | 941 | Pfam | PF01302 | CAP-Gly domain | 6 | 70 | 2.2E-23 | T | 22-09-2020 | IPR000938 | CAP Gly-rich domain |
| UnnamedSample_HQ_transcript/24662|m.8120 | UnnamedSample_HQ_transcript/24662 | Coverage 0.780 too low. | d3084ccdc5013113eea4b85fd76d8002 | 941 | Pfam | PF12455 | Dynein associated protein | 498 | 780 | 4.8E-77 | T | 22-09-2020 | IPR022157 | Dynein associated protein |
| UnnamedSample_HQ_transcript/1062|m.659 | UnnamedSample_HQ_transcript/1062 | Coverage 0.956 too low. | 5c581e03bebf6c0ce8f25425554a051e | 2108 | Pfam | PF10351 | Golgi-body localisation protein domain | 1748 | 2097 | 1.1E-76 | T | 22-09-2020 | IPR019443 | FMP27, C-terminal |
| UnnamedSample_HQ_transcript/1062|m.659 | UnnamedSample_HQ_transcript/1062 | Coverage 0.956 too low. | 5c581e03bebf6c0ce8f25425554a051e | 2108 | Pfam | PF10293 | Domain of unknown function (DUF2405) | 876 | 940 | 1.1E-5 | T | 22-09-2020 | IPR019409 | FMP27, domain of unknown function DUF2405 |
| UnnamedSample_HQ_transcript/1062|m.659 | UnnamedSample_HQ_transcript/1062 | Coverage 0.956 too low. | 5c581e03bebf6c0ce8f25425554a051e | 2108 | Pfam | PF10347 | RNA pol II promoter Fmp27 protein domain | 1047 | 1178 | 3.8E-29 | T | 22-09-2020 | IPR019441 | FMP27, GFWDK domain |
| UnnamedSample_HQ_transcript/74941|m.18821 | UnnamedSample_HQ_transcript/74941 | Coverage 0.276 too low. | ccd706c6b1351dd7f830505d9bf2794f | 399 | Pfam | PF10324 | Serpentine type 7TM GPCR chemoreceptor Srw | 44 | 361 | 2.1E-38 | T | 22-09-2020 | IPR019427 | 7TM GPCR, serpentine receptor class w (Srw) |
| UnnamedSample_HQ_transcript/1962|m.1039 | UnnamedSample_HQ_transcript/1962 | Coverage 0.962 too low. | 7a7ad6962c9d9a6d1124b5714445c91b | 975 | Pfam | PF00010 | Helix-loop-helix DNA-binding domain | 40 | 89 | 1.6E-11 | T | 22-09-2020 | IPR011598 | Myc-type, basic helix-loop-helix (bHLH) domain |
| UnnamedSample_HQ_transcript/1962|m.1039 | UnnamedSample_HQ_transcript/1962 | Coverage 0.962 too low. | 7a7ad6962c9d9a6d1124b5714445c91b | 975 | Pfam | PF14598 | PAS domain | 278 | 385 | 1.7E-18 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/5907|m.2506 | UnnamedSample_HQ_transcript/5907 | Coverage 0.969 too low. | 7a7ad6962c9d9a6d1124b5714445c91b | 975 | Pfam | PF00010 | Helix-loop-helix DNA-binding domain | 40 | 89 | 1.6E-11 | T | 22-09-2020 | IPR011598 | Myc-type, basic helix-loop-helix (bHLH) domain |
| UnnamedSample_HQ_transcript/5907|m.2506 | UnnamedSample_HQ_transcript/5907 | Coverage 0.969 too low. | 7a7ad6962c9d9a6d1124b5714445c91b | 975 | Pfam | PF14598 | PAS domain | 278 | 385 | 1.7E-18 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/5387|m.2330 | UnnamedSample_HQ_transcript/5387 | Coverage 0.951 too low. | 7a7ad6962c9d9a6d1124b5714445c91b | 975 | Pfam | PF00010 | Helix-loop-helix DNA-binding domain | 40 | 89 | 1.6E-11 | T | 22-09-2020 | IPR011598 | Myc-type, basic helix-loop-helix (bHLH) domain |
| UnnamedSample_HQ_transcript/5387|m.2330 | UnnamedSample_HQ_transcript/5387 | Coverage 0.951 too low. | 7a7ad6962c9d9a6d1124b5714445c91b | 975 | Pfam | PF14598 | PAS domain | 278 | 385 | 1.7E-18 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/5495|m.2361 | UnnamedSample_HQ_transcript/5495 | Coverage 0.948 too low. | 7a7ad6962c9d9a6d1124b5714445c91b | 975 | Pfam | PF00010 | Helix-loop-helix DNA-binding domain | 40 | 89 | 1.6E-11 | T | 22-09-2020 | IPR011598 | Myc-type, basic helix-loop-helix (bHLH) domain |
| UnnamedSample_HQ_transcript/5495|m.2361 | UnnamedSample_HQ_transcript/5495 | Coverage 0.948 too low. | 7a7ad6962c9d9a6d1124b5714445c91b | 975 | Pfam | PF14598 | PAS domain | 278 | 385 | 1.7E-18 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/20422|m.6980 | UnnamedSample_HQ_transcript/20422 | Coverage 0.955 too low. | 81141ee20ab398f5a12eacbdc8a64a9c | 1026 | Pfam | PF00621 | RhoGEF domain | 549 | 717 | 2.9E-36 | T | 22-09-2020 | IPR000219 | Dbl homology (DH) domain |
| UnnamedSample_HQ_transcript/20422|m.6980 | UnnamedSample_HQ_transcript/20422 | Coverage 0.955 too low. | 81141ee20ab398f5a12eacbdc8a64a9c | 1026 | Pfam | PF00435 | Spectrin repeat | 399 | 501 | 2.7E-9 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/20422|m.6980 | UnnamedSample_HQ_transcript/20422 | Coverage 0.955 too low. | 81141ee20ab398f5a12eacbdc8a64a9c | 1026 | Pfam | PF00435 | Spectrin repeat | 173 | 274 | 1.4E-15 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/86279|m.20689 | UnnamedSample_HQ_transcript/86279 | Coverage 0.563 too low. | 70a29f213ecbc672ee36f1c6e0f51a6d | 362 | Pfam | PF17900 | Peptidase M1 N-terminal domain | 28 | 215 | 6.6E-46 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/86279|m.20689 | UnnamedSample_HQ_transcript/86279 | Coverage 0.563 too low. | 70a29f213ecbc672ee36f1c6e0f51a6d | 362 | Pfam | PF01433 | Peptidase family M1 domain | 247 | 355 | 3.5E-39 | T | 22-09-2020 | IPR014782 | Peptidase M1, membrane alanine aminopeptidase |
| UnnamedSample_HQ_transcript/103014|m.22995 | UnnamedSample_HQ_transcript/103014 | Identity 0.390 too low. | f8673d614c4668db6100045e423c9026 | 222 | Pfam | PF01395 | PBP/GOBP family | 29 | 114 | 1.1E-4 | T | 22-09-2020 | IPR006170 | Pheromone/general odorant binding protein |
| UnnamedSample_HQ_transcript/65982|m.17205 | UnnamedSample_HQ_transcript/65982 | Coverage 0.815 too low. | ecf56e3e0a07c28471935947803bb6ca | 399 | Pfam | PF01429 | Methyl-CpG binding domain | 8 | 47 | 6.3E-5 | T | 22-09-2020 | IPR001739 | Methyl-CpG DNA binding |
| UnnamedSample_HQ_transcript/65982|m.17205 | UnnamedSample_HQ_transcript/65982 | Coverage 0.815 too low. | ecf56e3e0a07c28471935947803bb6ca | 399 | Pfam | PF05033 | Pre-SET motif | 69 | 181 | 7.9E-16 | T | 22-09-2020 | IPR007728 | Pre-SET domain |
| UnnamedSample_HQ_transcript/65982|m.17205 | UnnamedSample_HQ_transcript/65982 | Coverage 0.815 too low. | ecf56e3e0a07c28471935947803bb6ca | 399 | Pfam | PF00856 | SET domain | 200 | 387 | 7.4E-18 | T | 22-09-2020 | IPR001214 | SET domain |
| UnnamedSample_HQ_transcript/77113|m.19220 | UnnamedSample_HQ_transcript/77113 | Coverage 0.811 too low. | 47fc47541cbba13820c26135038befed | 431 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.4E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/104120|m.23119 | UnnamedSample_HQ_transcript/104120 | Coverage 0.747 too low. | 340d524e56a7987c30c7e64ecb3821fe | 198 | Pfam | PF13869 | Nucleotide hydrolase | 45 | 190 | 6.5E-59 | T | 22-09-2020 | IPR016706 | Cleavage/polyadenylation specificity factor subunit 5 |
| UnnamedSample_HQ_transcript/114456|m.24340 | UnnamedSample_HQ_transcript/114456 | Coverage 0.694 too low. | e5ad96340e575f37cedf1a44d5baa5fe | 174 | Pfam | PF01467 | Cytidylyltransferase-like | 1 | 145 | 4.9E-9 | T | 22-09-2020 | IPR004821 | Cytidyltransferase-like domain |
| UnnamedSample_HQ_transcript/71924|m.18285 | UnnamedSample_HQ_transcript/71924 | Coverage 0.358 too low. | d41ce56efd1eb91046896c97c3ff5e93 | 128 | Pfam | PF08347 | N-terminal CTNNB1 binding | 6 | 75 | 8.0E-7 | T | 22-09-2020 | IPR013558 | CTNNB1 binding, N-teminal |
| UnnamedSample_HQ_transcript/45583|m.13053 | UnnamedSample_HQ_transcript/45583 | Coverage 0.162 too low. | 93dedf400f7b4c06ef6251c98595ba72 | 640 | Pfam | PF07679 | Immunoglobulin I-set domain | 119 | 211 | 6.6E-20 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/45583|m.13053 | UnnamedSample_HQ_transcript/45583 | Coverage 0.162 too low. | 93dedf400f7b4c06ef6251c98595ba72 | 640 | Pfam | PF07679 | Immunoglobulin I-set domain | 9 | 102 | 4.1E-14 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/45583|m.13053 | UnnamedSample_HQ_transcript/45583 | Coverage 0.162 too low. | 93dedf400f7b4c06ef6251c98595ba72 | 640 | Pfam | PF07679 | Immunoglobulin I-set domain | 425 | 512 | 2.0E-5 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/45583|m.13053 | UnnamedSample_HQ_transcript/45583 | Coverage 0.162 too low. | 93dedf400f7b4c06ef6251c98595ba72 | 640 | Pfam | PF07679 | Immunoglobulin I-set domain | 330 | 420 | 1.1E-13 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/45583|m.13053 | UnnamedSample_HQ_transcript/45583 | Coverage 0.162 too low. | 93dedf400f7b4c06ef6251c98595ba72 | 640 | Pfam | PF07679 | Immunoglobulin I-set domain | 223 | 316 | 3.4E-16 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/45583|m.13053 | UnnamedSample_HQ_transcript/45583 | Coverage 0.162 too low. | 93dedf400f7b4c06ef6251c98595ba72 | 640 | Pfam | PF07679 | Immunoglobulin I-set domain | 528 | 618 | 1.1E-12 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/45631|m.13065 | UnnamedSample_HQ_transcript/45631 | Coverage 0.160 too low. | 93dedf400f7b4c06ef6251c98595ba72 | 640 | Pfam | PF07679 | Immunoglobulin I-set domain | 119 | 211 | 6.6E-20 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/45631|m.13065 | UnnamedSample_HQ_transcript/45631 | Coverage 0.160 too low. | 93dedf400f7b4c06ef6251c98595ba72 | 640 | Pfam | PF07679 | Immunoglobulin I-set domain | 9 | 102 | 4.1E-14 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/45631|m.13065 | UnnamedSample_HQ_transcript/45631 | Coverage 0.160 too low. | 93dedf400f7b4c06ef6251c98595ba72 | 640 | Pfam | PF07679 | Immunoglobulin I-set domain | 425 | 512 | 2.0E-5 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/45631|m.13065 | UnnamedSample_HQ_transcript/45631 | Coverage 0.160 too low. | 93dedf400f7b4c06ef6251c98595ba72 | 640 | Pfam | PF07679 | Immunoglobulin I-set domain | 330 | 420 | 1.1E-13 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/45631|m.13065 | UnnamedSample_HQ_transcript/45631 | Coverage 0.160 too low. | 93dedf400f7b4c06ef6251c98595ba72 | 640 | Pfam | PF07679 | Immunoglobulin I-set domain | 223 | 316 | 3.4E-16 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/45631|m.13065 | UnnamedSample_HQ_transcript/45631 | Coverage 0.160 too low. | 93dedf400f7b4c06ef6251c98595ba72 | 640 | Pfam | PF07679 | Immunoglobulin I-set domain | 528 | 618 | 1.1E-12 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/52273|m.14502 | UnnamedSample_HQ_transcript/52273 | Coverage 0.070 too low. | 93dedf400f7b4c06ef6251c98595ba72 | 640 | Pfam | PF07679 | Immunoglobulin I-set domain | 119 | 211 | 6.6E-20 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/52273|m.14502 | UnnamedSample_HQ_transcript/52273 | Coverage 0.070 too low. | 93dedf400f7b4c06ef6251c98595ba72 | 640 | Pfam | PF07679 | Immunoglobulin I-set domain | 9 | 102 | 4.1E-14 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/52273|m.14502 | UnnamedSample_HQ_transcript/52273 | Coverage 0.070 too low. | 93dedf400f7b4c06ef6251c98595ba72 | 640 | Pfam | PF07679 | Immunoglobulin I-set domain | 425 | 512 | 2.0E-5 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/52273|m.14502 | UnnamedSample_HQ_transcript/52273 | Coverage 0.070 too low. | 93dedf400f7b4c06ef6251c98595ba72 | 640 | Pfam | PF07679 | Immunoglobulin I-set domain | 330 | 420 | 1.1E-13 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/52273|m.14502 | UnnamedSample_HQ_transcript/52273 | Coverage 0.070 too low. | 93dedf400f7b4c06ef6251c98595ba72 | 640 | Pfam | PF07679 | Immunoglobulin I-set domain | 223 | 316 | 3.4E-16 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/52273|m.14502 | UnnamedSample_HQ_transcript/52273 | Coverage 0.070 too low. | 93dedf400f7b4c06ef6251c98595ba72 | 640 | Pfam | PF07679 | Immunoglobulin I-set domain | 528 | 618 | 1.1E-12 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/57093|m.15467 | UnnamedSample_HQ_transcript/57093 | Coverage 0.967 too low. | 93dedf400f7b4c06ef6251c98595ba72 | 640 | Pfam | PF07679 | Immunoglobulin I-set domain | 119 | 211 | 6.6E-20 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/57093|m.15467 | UnnamedSample_HQ_transcript/57093 | Coverage 0.967 too low. | 93dedf400f7b4c06ef6251c98595ba72 | 640 | Pfam | PF07679 | Immunoglobulin I-set domain | 9 | 102 | 4.1E-14 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/57093|m.15467 | UnnamedSample_HQ_transcript/57093 | Coverage 0.967 too low. | 93dedf400f7b4c06ef6251c98595ba72 | 640 | Pfam | PF07679 | Immunoglobulin I-set domain | 425 | 512 | 2.0E-5 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/57093|m.15467 | UnnamedSample_HQ_transcript/57093 | Coverage 0.967 too low. | 93dedf400f7b4c06ef6251c98595ba72 | 640 | Pfam | PF07679 | Immunoglobulin I-set domain | 330 | 420 | 1.1E-13 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/57093|m.15467 | UnnamedSample_HQ_transcript/57093 | Coverage 0.967 too low. | 93dedf400f7b4c06ef6251c98595ba72 | 640 | Pfam | PF07679 | Immunoglobulin I-set domain | 223 | 316 | 3.4E-16 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/57093|m.15467 | UnnamedSample_HQ_transcript/57093 | Coverage 0.967 too low. | 93dedf400f7b4c06ef6251c98595ba72 | 640 | Pfam | PF07679 | Immunoglobulin I-set domain | 528 | 618 | 1.1E-12 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/57704|m.15595 | UnnamedSample_HQ_transcript/57704 | Coverage 0.548 too low. | 643ad0997c06ac62240852a7aba6856b | 630 | Pfam | PF16367 | RNA recognition motif | 433 | 522 | 3.9E-32 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/30655|m.9633 | UnnamedSample_HQ_transcript/30655 | Coverage 0.571 too low. | 7fc1fe0d510b5f0353a60c2ec63c15b5 | 460 | Pfam | PF01770 | Reduced folate carrier | 14 | 431 | 1.5E-136 | T | 22-09-2020 | IPR002666 | Reduced folate carrier |
| UnnamedSample_HQ_transcript/22402|m.7544 | UnnamedSample_HQ_transcript/22402 | Coverage 0.539 too low. | 7fc1fe0d510b5f0353a60c2ec63c15b5 | 460 | Pfam | PF01770 | Reduced folate carrier | 14 | 431 | 1.5E-136 | T | 22-09-2020 | IPR002666 | Reduced folate carrier |
| UnnamedSample_HQ_transcript/12409|m.4625 | UnnamedSample_HQ_transcript/12409 | Identity 0.523 too low. | 7fc1fe0d510b5f0353a60c2ec63c15b5 | 460 | Pfam | PF01770 | Reduced folate carrier | 14 | 431 | 1.5E-136 | T | 22-09-2020 | IPR002666 | Reduced folate carrier |
| UnnamedSample_HQ_transcript/18955|m.6565 | UnnamedSample_HQ_transcript/18955 | Coverage 0.565 too low. | 7fc1fe0d510b5f0353a60c2ec63c15b5 | 460 | Pfam | PF01770 | Reduced folate carrier | 14 | 431 | 1.5E-136 | T | 22-09-2020 | IPR002666 | Reduced folate carrier |
| UnnamedSample_HQ_transcript/18476|m.6441 | UnnamedSample_HQ_transcript/18476 | Identity 0.499 too low. | 7fc1fe0d510b5f0353a60c2ec63c15b5 | 460 | Pfam | PF01770 | Reduced folate carrier | 14 | 431 | 1.5E-136 | T | 22-09-2020 | IPR002666 | Reduced folate carrier |
| UnnamedSample_HQ_transcript/19978|m.6867 | UnnamedSample_HQ_transcript/19978 | Identity 0.483 too low. | 7fc1fe0d510b5f0353a60c2ec63c15b5 | 460 | Pfam | PF01770 | Reduced folate carrier | 14 | 431 | 1.5E-136 | T | 22-09-2020 | IPR002666 | Reduced folate carrier |
| UnnamedSample_HQ_transcript/24654|m.8118 | UnnamedSample_HQ_transcript/24654 | Coverage 0.524 too low. | 7fc1fe0d510b5f0353a60c2ec63c15b5 | 460 | Pfam | PF01770 | Reduced folate carrier | 14 | 431 | 1.5E-136 | T | 22-09-2020 | IPR002666 | Reduced folate carrier |
| UnnamedSample_HQ_transcript/28055|m.8984 | UnnamedSample_HQ_transcript/28055 | Coverage 0.587 too low. | 7fc1fe0d510b5f0353a60c2ec63c15b5 | 460 | Pfam | PF01770 | Reduced folate carrier | 14 | 431 | 1.5E-136 | T | 22-09-2020 | IPR002666 | Reduced folate carrier |
| UnnamedSample_HQ_transcript/49136|m.13837 | UnnamedSample_HQ_transcript/49136 | Coverage 0.409 too low. | e91050e2e96cc0231f9eca3a502ed0f4 | 557 | Pfam | PF00435 | Spectrin repeat | 418 | 507 | 3.9E-6 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/66542|m.17323 | UnnamedSample_HQ_transcript/66542 | Identity 0.761 too low. | 205b4d815ca29118c85aeb39986c98ad | 573 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 96 | 133 | 5.2E-9 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/66542|m.17323 | UnnamedSample_HQ_transcript/66542 | Identity 0.761 too low. | 205b4d815ca29118c85aeb39986c98ad | 573 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 55 | 92 | 2.3E-9 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/66542|m.17323 | UnnamedSample_HQ_transcript/66542 | Identity 0.761 too low. | 205b4d815ca29118c85aeb39986c98ad | 573 | Pfam | PF00089 | Trypsin | 306 | 552 | 3.9E-30 | T | 22-09-2020 | IPR001254 | Serine proteases, trypsin domain |
| UnnamedSample_HQ_transcript/82120|m.20051 | UnnamedSample_HQ_transcript/82120 | Coverage 0.989 too low. | eb17d6ac7d67966fdea471707dea114b | 445 | Pfam | PF01576 | Myosin tail | 74 | 443 | 1.5E-58 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/23751|m.7878 | UnnamedSample_HQ_transcript/23751 | Identity 0.891 too low. | cd0d4804c95210566736501ee3d0a37a | 794 | Pfam | PF01044 | Vinculin family | 1 | 792 | 1.0E-281 | T | 22-09-2020 | IPR006077 | Vinculin/alpha-catenin |
| UnnamedSample_HQ_transcript/20822|m.7097 | UnnamedSample_HQ_transcript/20822 | Coverage 0.033 too low. | 991647bed24a2a57a7f315ad1b434198 | 884 | Pfam | PF07727 | Reverse transcriptase (RNA-dependent DNA polymerase) | 411 | 647 | 2.2E-53 | T | 22-09-2020 | IPR013103 | Reverse transcriptase, RNA-dependent DNA polymerase |
| UnnamedSample_HQ_transcript/20822|m.7097 | UnnamedSample_HQ_transcript/20822 | Coverage 0.033 too low. | 991647bed24a2a57a7f315ad1b434198 | 884 | Pfam | PF13976 | GAG-pre-integrase domain | 48 | 108 | 5.1E-7 | T | 22-09-2020 | IPR025724 | GAG-pre-integrase domain |
| UnnamedSample_HQ_transcript/20822|m.7097 | UnnamedSample_HQ_transcript/20822 | Coverage 0.033 too low. | 991647bed24a2a57a7f315ad1b434198 | 884 | Pfam | PF00665 | Integrase core domain | 122 | 218 | 8.5E-12 | T | 22-09-2020 | IPR001584 | Integrase, catalytic core |
| UnnamedSample_HQ_transcript/21900|m.7400 | UnnamedSample_HQ_transcript/21900 | Coverage 0.986 too low. | d85a817e28783aa3696ed0ae1b535a0b | 910 | Pfam | PF13894 | C2H2-type zinc finger | 554 | 576 | 5.2E-4 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/21900|m.7400 | UnnamedSample_HQ_transcript/21900 | Coverage 0.986 too low. | d85a817e28783aa3696ed0ae1b535a0b | 910 | Pfam | PF13894 | C2H2-type zinc finger | 301 | 323 | 2.8E-4 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/21900|m.7400 | UnnamedSample_HQ_transcript/21900 | Coverage 0.986 too low. | d85a817e28783aa3696ed0ae1b535a0b | 910 | Pfam | PF13912 | C2H2-type zinc finger | 613 | 635 | 0.028 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/21900|m.7400 | UnnamedSample_HQ_transcript/21900 | Coverage 0.986 too low. | d85a817e28783aa3696ed0ae1b535a0b | 910 | Pfam | PF00096 | Zinc finger, C2H2 type | 496 | 518 | 3.1E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/21900|m.7400 | UnnamedSample_HQ_transcript/21900 | Coverage 0.986 too low. | d85a817e28783aa3696ed0ae1b535a0b | 910 | Pfam | PF00096 | Zinc finger, C2H2 type | 724 | 746 | 8.2E-5 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/21900|m.7400 | UnnamedSample_HQ_transcript/21900 | Coverage 0.986 too low. | d85a817e28783aa3696ed0ae1b535a0b | 910 | Pfam | PF00096 | Zinc finger, C2H2 type | 696 | 718 | 0.0025 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/21900|m.7400 | UnnamedSample_HQ_transcript/21900 | Coverage 0.986 too low. | d85a817e28783aa3696ed0ae1b535a0b | 910 | Pfam | PF00096 | Zinc finger, C2H2 type | 640 | 662 | 2.8E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/21900|m.7400 | UnnamedSample_HQ_transcript/21900 | Coverage 0.986 too low. | d85a817e28783aa3696ed0ae1b535a0b | 910 | Pfam | PF00096 | Zinc finger, C2H2 type | 273 | 295 | 8.5E-6 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/21900|m.7400 | UnnamedSample_HQ_transcript/21900 | Coverage 0.986 too low. | d85a817e28783aa3696ed0ae1b535a0b | 910 | Pfam | PF00096 | Zinc finger, C2H2 type | 468 | 490 | 1.1E-6 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/21900|m.7400 | UnnamedSample_HQ_transcript/21900 | Coverage 0.986 too low. | d85a817e28783aa3696ed0ae1b535a0b | 910 | Pfam | PF00096 | Zinc finger, C2H2 type | 440 | 462 | 0.0012 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/21900|m.7400 | UnnamedSample_HQ_transcript/21900 | Coverage 0.986 too low. | d85a817e28783aa3696ed0ae1b535a0b | 910 | Pfam | PF00096 | Zinc finger, C2H2 type | 245 | 267 | 1.9E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/21900|m.7400 | UnnamedSample_HQ_transcript/21900 | Coverage 0.986 too low. | d85a817e28783aa3696ed0ae1b535a0b | 910 | Pfam | PF00096 | Zinc finger, C2H2 type | 752 | 774 | 3.9E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/21900|m.7400 | UnnamedSample_HQ_transcript/21900 | Coverage 0.986 too low. | d85a817e28783aa3696ed0ae1b535a0b | 910 | Pfam | PF00096 | Zinc finger, C2H2 type | 780 | 802 | 0.0054 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/21900|m.7400 | UnnamedSample_HQ_transcript/21900 | Coverage 0.986 too low. | d85a817e28783aa3696ed0ae1b535a0b | 910 | Pfam | PF00096 | Zinc finger, C2H2 type | 668 | 690 | 1.8E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/4515|m.2004 | UnnamedSample_HQ_transcript/4515 | Coverage 0.864 too low. | db578fbcf80a56bfd426252623bbb21b | 912 | Pfam | PF00754 | F5/8 type C domain | 47 | 184 | 7.1E-18 | T | 22-09-2020 | IPR000421 | Coagulation factor 5/8 C-terminal domain |
| UnnamedSample_HQ_transcript/4515|m.2004 | UnnamedSample_HQ_transcript/4515 | Coverage 0.864 too low. | db578fbcf80a56bfd426252623bbb21b | 912 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 620 | 900 | 4.0E-78 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/40781|m.12024 | UnnamedSample_HQ_transcript/40781 | Coverage 0.350 too low. | 174f144cfbec806502b79660e2acdc95 | 594 | Pfam | PF01130 | CD36 family | 92 | 559 | 3.8E-97 | T | 22-09-2020 | IPR002159 | CD36 family |
| UnnamedSample_HQ_transcript/37613|m.11301 | UnnamedSample_HQ_transcript/37613 | Coverage 0.966 too low. | 4133adc80b3881984df1ab43df623ed2 | 591 | Pfam | PF08153 | NGP1NT (NUC091) domain | 32 | 162 | 3.7E-48 | T | 22-09-2020 | IPR012971 | Nucleolar GTP-binding protein 2, N-terminal domain |
| UnnamedSample_HQ_transcript/37613|m.11301 | UnnamedSample_HQ_transcript/37613 | Coverage 0.966 too low. | 4133adc80b3881984df1ab43df623ed2 | 591 | Pfam | PF01926 | 50S ribosome-binding GTPase | 301 | 361 | 9.0E-14 | T | 22-09-2020 | IPR006073 | GTP binding domain |
| UnnamedSample_HQ_transcript/109637|m.23790 | UnnamedSample_HQ_transcript/109637 | Coverage 0.988 too low. | 400f209247297edfacd4da1aa1dc4283 | 263 | Pfam | PF00975 | Thioesterase domain | 12 | 233 | 4.1E-15 | T | 22-09-2020 | IPR001031 | Thioesterase |
| UnnamedSample_HQ_transcript/12575|m.4685 | UnnamedSample_HQ_transcript/12575 | Identity 0.900 too low. | 89a0d7cad7347696f2575ded1c294905 | 1129 | Pfam | PF08399 | VWA N-terminal | 56 | 172 | 8.7E-30 | T | 22-09-2020 | IPR013608 | VWA N-terminal |
| UnnamedSample_HQ_transcript/12575|m.4685 | UnnamedSample_HQ_transcript/12575 | Identity 0.900 too low. | 89a0d7cad7347696f2575ded1c294905 | 1129 | Pfam | PF08473 | Neuronal voltage-dependent calcium channel alpha 2acd | 684 | 1002 | 5.4E-18 | T | 22-09-2020 | IPR013680 | Voltage-dependent calcium channel, alpha-2/delta subunit, conserved region |
| UnnamedSample_HQ_transcript/17896|m.6267 | UnnamedSample_HQ_transcript/17896 | Coverage 0.250 too low. | b8be7234af1d0bf78b706c8862650ad8 | 965 | Pfam | PF00788 | Ras association (RalGDS/AF-6) domain | 830 | 904 | 5.3E-5 | T | 22-09-2020 | IPR000159 | Ras-associating (RA) domain |
| UnnamedSample_HQ_transcript/17896|m.6267 | UnnamedSample_HQ_transcript/17896 | Coverage 0.250 too low. | b8be7234af1d0bf78b706c8862650ad8 | 965 | Pfam | PF00620 | RhoGAP domain | 620 | 770 | 2.6E-39 | T | 22-09-2020 | IPR000198 | Rho GTPase-activating protein domain |
| UnnamedSample_HQ_transcript/17896|m.6267 | UnnamedSample_HQ_transcript/17896 | Coverage 0.250 too low. | b8be7234af1d0bf78b706c8862650ad8 | 965 | Pfam | PF00169 | PH domain | 393 | 492 | 3.9E-6 | T | 22-09-2020 | IPR001849 | Pleckstrin homology domain |
| UnnamedSample_HQ_transcript/34651|m.10638 | UnnamedSample_HQ_transcript/34651 | Coverage 0.123 too low. | 153f222ca7c37d5a914ee03e6453c2b6 | 665 | Pfam | PF08373 | RAP domain | 597 | 643 | 6.7E-8 | T | 22-09-2020 | IPR013584 | RAP domain |
| UnnamedSample_HQ_transcript/33838|m.10420 | UnnamedSample_HQ_transcript/33838 | Coverage 0.146 too low. | 153f222ca7c37d5a914ee03e6453c2b6 | 665 | Pfam | PF08373 | RAP domain | 597 | 643 | 6.7E-8 | T | 22-09-2020 | IPR013584 | RAP domain |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
